Does Blue Cross Blue Shield Cover Phentermine (Adipex-P / Lomaira)?
The verdict
Conditional on most plans
Whether BCBS covers phentermine depends entirely on whether your specific plan includes a weight-loss or anti-obesity-medication benefit. Phentermine is FDA-approved only for short-term weight management (approximately 12 weeks) and is a DEA Schedule IV controlled substance, so plans with an AOM carve-out exclude it outright. Standard Medicare Part D excludes it by statute. The silver lining: where plans do cover weight-loss drugs, generic phentermine is frequently the low-cost preferred non-incretin AOM, and some payers even require a phentermine trial before approving a GLP-1. At roughly $10–$40 cash for the generic, coverage is rarely worth the effort. Note that 'Blue Cross Blue Shield' represents more than 30 independent companies — your specific BCBS plan may differ; always verify on your plan's drug-search tool.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Blue Cross Blue Shield using your member ID.
Key facts
Generic phentermine costs approximately $10–$40 per month cash — the least expensive FDA-approved weight-loss prescription in the cluster.
Drugs.com / GoodRx cash-price data
Only 19% of firms with 200+ workers covered GLP-1s for weight loss in their largest plan (2025 KFF Employer Health Benefits Survey) — oral AOM coverage follows a similar pattern.
KFF Employer Health Benefits Survey, Oct. 2025
Medicare Part D has statutorily excluded weight-loss agents, including phentermine, since Part D's creation in 2006. The 2026 GLP-1 Bridge does not include phentermine.
CMS.gov / Medicare.gov GLP-1 Bridge fact sheet
Medicare vs. commercial coverage
Whether Blue Cross Blue Shield covers Phentermine (Adipex-P / Lomaira) depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Standard Medicare Part D statutorily excludes phentermine as a weight-loss agent. This exclusion dates to the 2003/2006 Medicare Modernization Act and applies across all Part D and Medicare Advantage plans, including BCBS Medicare plans. Phentermine is NOT included in the 2026 Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027), which covers only specified weight-loss GLP-1s — Wegovy formulations, Foundayo, and the Zepbound KwikPen. Medicare beneficiaries are also ineligible for manufacturer copay cards under federal anti-kickback rules. At $10–$40 for the generic, cash is the operative route.
Commercial / Employer
Group & marketplace plans
BCBS commercial and employer plans cover phentermine only if the employer group has elected a weight-loss or anti-obesity-medication benefit — and many have not. Per the 2025 KFF Employer Health Benefits Survey, only 19% of firms with 200+ workers covered GLP-1s for weight loss; oral AOMs follow a similar pattern. Where covered, generic phentermine is often the lowest-cost preferred anti-obesity option on the formulary and may be a required step-therapy before a GLP-1 (such as Wegovy or Zepbound) is approved. Prior authorization where applied: BMI of 30 or higher, or 27 or higher with a qualifying comorbidity (hypertension, T2D, dyslipidemia, OSA, CVD). DEA Schedule IV quantity limits apply; typical approvals are short-term (approximately 12 weeks). ACA marketplace plans are frequently more restrictive and often exclude anti-obesity medications. State Medicaid: some state Medicaid programs (North Carolina's PDL is one well-documented example) keep generic phentermine, diethylpropion, and phendimetrazine as preferred non-incretin agents without prior authorization — a more favorable posture than GLP-1 coverage. Coverage varies by specific BCBS company and state; cells are representative composites. Verify on your specific BCBS plan's drug-search tool.
The 4 boxes you must tick to get approved
Commercial plans that will consider Phentermine (Adipex-P / Lomaira) require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
0 of 4 requirements selected. Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Phentermine (Adipex-P / Lomaira) actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Generic phentermine: approximately $40 retail per month, as low as $10 with a discount coupon (GoodRx / SingleCare). Brand Adipex-P and Lomaira carry higher costs; the generic is the near-universal fill.
List price with no coverage — before any manufacturer savings card.
With coverage
Where phentermine is covered, generic tier co-pays are typically low — often $0–$15 per month. Confirm with your specific BCBS plan formulary.
Typical monthly copay once prior authorization is approved.
No broad manufacturer copay card is available for phentermine (the Adipex-P manufacturer copay program was discontinued February 1, 2024). Some states restrict or prohibit discount coupons on Schedule IV controlled substances — check your state's rules before using a coupon. All figures are estimates; verify with your plan and pharmacy.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Check whether your BCBS plan includes a weight-loss or AOM benefit
Log into your BCBS member portal (bcbs.com or your specific state affiliate's site) with your member ID and look up phentermine or 'anti-obesity medications' in the drug-search tool. If the search returns no coverage, your plan likely has an AOM carve-out — confirm with member services or your HR department. Remember that BCBS is 30+ independent companies; results vary by affiliate.
- 2
Confirm the Schedule IV controlled-substance and short-term-use requirements with your prescriber
Phentermine is a DEA Schedule IV controlled substance approved for approximately 12 weeks of use. Your prescriber must document your BMI and qualifying comorbidities to support a prior authorization if your plan requires one. Discuss whether phentermine is a one-time short-term course or whether your plan requires it as a step before considering a GLP-1.
- 3
Use the coupon route if excluded — the generic is $10–$40
If your BCBS plan excludes phentermine, the most practical route is cash with a discount coupon. Generic phentermine is among the cheapest prescription weight-loss options available — typically $10–$40 per month with GoodRx or a pharmacy discount program. No prescription appeal is needed; just ask your prescriber for a cash prescription. Note that some states bar coupons on controlled substances; verify in your state.
Options if Blue Cross Blue Shield won't cover Phentermine (Adipex-P / Lomaira)
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Contrave (naltrexone/bupropion)
Contrave is another FDA-approved oral anti-obesity agent, but there is no generic and the retail price runs $619–$753 per month. The Currax CurAccess cash program offers it at approximately $99 per month — still far more expensive than phentermine's generic.
Qsymia (phentermine/topiramate ER) — generic available 2025
Qsymia is phentermine combined with extended-release topiramate. The Vivus Engage cash program is approximately $89 per month; a generic launched in 2025 (Teva) is available for approximately $63 with a coupon. It requires a REMS program and has teratogenic risks from topiramate.
Weight-loss GLP-1s (Wegovy, Zepbound) — if your plan has the AOM benefit
If your BCBS plan covers weight-loss drugs, a GLP-1 may offer greater long-term efficacy. PA requires BMI ≥30 or ≥27 with a comorbidity. Some plans require a phentermine or Contrave trial first.
These options are listed for information only — your own clinician decides what is appropriate for you.
Frequently Asked Questions
BCBS covers phentermine only if your specific plan includes an anti-obesity-medication benefit — many employer plans and all standard Medicare Part D plans exclude weight-loss drugs. Where covered, generic phentermine is often the preferred, lowest-cost AOM. Because the generic costs just $10–$40 cash, most patients find it cheaper to pay out of pocket than to navigate a prior authorization. Verify on your specific BCBS plan's drug-search tool.
No. Medicare Part D statutorily excludes phentermine and all other agents prescribed primarily for weight loss. This applies to all BCBS Medicare Advantage and Part D plans. Phentermine is not included in the 2026 Medicare GLP-1 Bridge, which covers only specified injectable weight-loss GLP-1s. For Medicare beneficiaries, the generic at $10–$40 cash is the realistic option; manufacturer copay cards are unavailable under federal rules.
Yes — some BCBS-administered plans require a documented trial of phentermine or Contrave before approving a weight-loss GLP-1 like Wegovy or Zepbound. This step-therapy requirement makes phentermine the gateway rather than the destination. At $10–$40 for the generic, completing that step is inexpensive even when paid out of pocket. Check your specific plan's step-therapy requirements before requesting a GLP-1 prior authorization.
'Blue Cross Blue Shield' represents more than 30 independent regional companies. Coverage varies widely between Anthem (Elevance), BCBS Texas, BCBS Michigan, Highmark, and others. Some affiliates cover phentermine with an AOM benefit rider; others exclude all weight-loss drugs. There is no single BCBS-wide formulary answer. Check your specific BCBS plan's member drug-search or contact member services with your plan ID to confirm phentermine coverage and any prior-authorization requirements.
No broad manufacturer coupon is currently available. The Adipex-P manufacturer copay program was discontinued on February 1, 2024. Third-party discount cards such as GoodRx and SingleCare reduce the generic to approximately $10–$40 per month at most pharmacies. Note that some states prohibit discount coupons on DEA Schedule IV controlled substances; verify that your state permits coupon use before presenting one at the pharmacy.
Related Articles
Does BCBS Michigan Cover Contrave? 2026 MI Guide | Curex
BCBS Michigan upheld weight-loss exclusions (DIFS 2025). Contrave is plan-dependent. MI Medicaid favors weight-loss GLP-1s; Contrave varies by PDL.
Read moreDoes BCBS of Illinois Cover Jardiance? 2026
BCBS of Illinois (HCSC) covers Jardiance across commercial, ACA, Medicare, and Medicaid. Metformin-first step is common. 2026 MFP $197 for Medicare.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes Blue Cross Blue Shield Cover Ambien? 2026 | Curex
Blue Cross Blue Shield covers generic zolpidem (Tier 1–2); brand Ambien is non-preferred. Quantity limits apply. Verify your specific BCBS plan for 2026.
Read moreDoes Blue Cross Blue Shield Cover Symbicort? 2026 | Curex
BCBS covers generic budesonide/formoterol as the preferred option; brand Symbicort is often non-preferred or excluded on Part D. Step therapy may apply.
Read moreIf BCBS excludes phentermine, a weight-management path that skips insurance is available
You just saw how tangled Phentermine (Adipex-P / Lomaira) coverage can get — auto-rejections, prior authorization, and high cash prices. Curex compounded semaglutide: $199/month equivalent prepaid annually ($2,388 upfront), or $299/month paid monthly. Compounded tirzepatide: $299/month equivalent prepaid annually ($3,588 upfront), or $399/month paid monthly. Commercial rates as of 2026-10-12; compounded products are not FDA-approved and clinical eligibility must be assessed. Curex compounded medications are not the same as Phentermine (Adipex-P / Lomaira). No insurance or prior authorization required; prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Phentermine (Adipex-P / Lomaira) and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Blue Cross Blue Shield before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Phentermine (Adipex-P / Lomaira) and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.